TrialClinical drug investigation2013

Bioequivalence of canakinumab liquid pre-filled syringe and reconstituted lyophilized formulations following 150 mg subcutaneous administration: a randomized study in healthy subjects.

Andrea Chioato et al.PubMed ↗Publisher ↗

No numbers read from the abstract.